IndraLab

Statements


ATP inhibits IKBKB. 4 / 4
| 4

reach
"Thus, earlier discovery efforts of pharmacological inhibitors of the NF-kappaB pathway were indeed aimed at developing ATP competitive inhibitors of IKK-2 activity [19,20]."

reach
"Taken together, these data suggest that the mechanisms of action of NBD peptides are distinct from those of ATP kinase inhibitors of IKK-2."

reach
"Pharmacological inhibition of NFkappaB p65 Serine (536) phosphorylation by SC-514, an ATP dependent competitive inhibitor of IKKbeta, significantly reduced p62 mRNA as well as protein levels in ARPE-19 cells under oxidative stress (XREF_FIG)."

reach
"Evaluation of small molecule ATP binding site inhibitors of IKKbeta re-inforces this concept although off-target side effects together with the compensatory activity of IKKalpha homodimers observed in the presence of IKKbeta inhibition may reduce their therapeutic efficacy XREF_BIBR, XREF_BIBR."